Anderson Edward T's Form 4 filing
Lyra Therapeutics, Inc. (LYRA) · filed Apr 14, 2022
- Accession no.
- 0000899243-22-014794
- Filed
- Apr 14, 2022
- Trade date
- Apr 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $10.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anderson Edward TCIK 0001218581 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2022 | Common Stock | PPurchaseAcquired | +1,076,851 | $4.22 | +$4,544,311.22 | 1,855,443 | Indirect | |
| Apr 12, 2022 | Common Stock | PPurchaseAcquired | +527,806 | $4.22 | +$2,227,341.32 | 909,424 | Indirect | |
| Apr 12, 2022 | Common Stock | PPurchaseAcquired | +765,010 | $4.22 | +$3,228,342.2 | 1,318,133 | Indirect | |
| Apr 12, 2022 | Common Stock | PPurchaseAcquired | +118,483 | $4.22 | +$499,998.26 | 118,483 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.